-
1
-
-
0032515029
-
-
(a) Liu, S.; Widom, J.; Kemp, C. W.; Crews, C. M.; Clardy, J. Science 1998, 282, 1324-1327.
-
(1998)
Science
, vol.282
, pp. 1324-1327
-
-
Liu, S.1
Widom, J.2
Kemp, C.W.3
Crews, C.M.4
Clardy, J.5
-
2
-
-
0030924753
-
-
(b) Sin, N.; Meng, L.; Wang, M. Q. W.; Wen, J. J.; Bornmann, W. G.; Crews, C. M. Proc. Natl. Acad. Sci. U.S.A., 1997, 94, 6099-6103.
-
(1997)
Proc. Natl. Acad. Sci. U.S.A.
, vol.94
, pp. 6099-6103
-
-
Sin, N.1
Meng, L.2
Wang, M.Q.W.3
Wen, J.J.4
Bornmann, W.G.5
Crews, C.M.6
-
3
-
-
0031171961
-
-
(c) Griffith, E. C.; Su, Z.; Turk, B. E.; Chen, S.; Chang, Y.; Wu, Z.; Biemann, K.; Liu, J. O. Chem. Biol. 1997, 4, 461-471.
-
(1997)
Chem. Biol.
, vol.4
, pp. 461-471
-
-
Griffith, E.C.1
Su, Z.2
Turk, B.E.3
Chen, S.4
Chang, Y.5
Wu, Z.6
Biemann, K.7
Liu, J.O.8
-
4
-
-
2342640861
-
-
However, recent data suggest that MetAP-2 inhibition does not necessarily correlate with antiangiogenic activity. Kim, S.; LaMontagne, K.; Sabio, M.; Sharma, S.; Versace, R. W.; Yusuff, N.; Phillips, P. E. Cancer Res. 2004, 64, 2984-2987.
-
(2004)
Cancer Res.
, vol.64
, pp. 2984-2987
-
-
Kim, S.1
LaMontagne, K.2
Sabio, M.3
Sharma, S.4
Versace, R.W.5
Yusuff, N.6
Phillips, P.E.7
-
5
-
-
0042343842
-
-
(a) Zhou, G.; Tsai, C. W.; Liu, J. O. J. Med. Chem. 2003, 46, 3452-3454.
-
(2003)
J. Med. Chem.
, vol.46
, pp. 3452-3454
-
-
Zhou, G.1
Tsai, C.W.2
Liu, J.O.3
-
6
-
-
10744229380
-
-
(b) Wang, J.; Sheppard, G. S.; Lou, P.; Kawai, M.; BaMaung, N.; Erickson, S. A.; Tucker-Garcia, L.; Park, C.; Bouska, J.; Wang, Y.-C.; Frost, D.; Tapang, P.; Albert, D. H.; Morgan, S. J.; Morowitz, M.; Shusterman, S.; Maris, J. M.; Lesniewski, R.; Henkin, J. Cancer Res. 2003, 63, 7861-7869.
-
(2003)
Cancer Res.
, vol.63
, pp. 7861-7869
-
-
Wang, J.1
Sheppard, G.S.2
Lou, P.3
Kawai, M.4
BaMaung, N.5
Erickson, S.A.6
Tucker-Garcia, L.7
Park, C.8
Bouska, J.9
Wang, Y.-C.10
Frost, D.11
Tapang, P.12
Albert, D.H.13
Morgan, S.J.14
Morowitz, M.15
Shusterman, S.16
Maris, J.M.17
Lesniewski, R.18
Henkin, J.19
-
7
-
-
2442612704
-
-
(c) Sendzik, M.; Janc, J. W.; Cabuslay, R.; Honigberg, L.; Mackman, R. L.; Magill, C.; Squires, N.; Waldeck, N. Bioorg. Med. Chem. Lett. 2004, 14, 3181-3184.
-
(2004)
Bioorg. Med. Chem. Lett.
, vol.14
, pp. 3181-3184
-
-
Sendzik, M.1
Janc, J.W.2
Cabuslay, R.3
Honigberg, L.4
Mackman, R.L.5
Magill, C.6
Squires, N.7
Waldeck, N.8
-
8
-
-
0347763342
-
-
Rodeschini, V.; Boiteau, J.-G.; Van de Weghe, P.; Tarnus, C.; Eustache, J. J. Org. Chem. 2004, 69, 357-373.
-
(2004)
J. Org. Chem.
, vol.69
, pp. 357-373
-
-
Rodeschini, V.1
Boiteau, J.-G.2
Van De Weghe, P.3
Tarnus, C.4
Eustache, J.5
-
9
-
-
0025874577
-
-
Ogawa, K.; Nagai, T.; Nomomura, M.; Takagi, T.; Koyama, M.; Ando, A.; Miki, T.; Kumadaki, I. Chem. Pharm. Bull. 1991, 39, 1707-1712.
-
(1991)
Chem. Pharm. Bull.
, vol.39
, pp. 1707-1712
-
-
Ogawa, K.1
Nagai, T.2
Nomomura, M.3
Takagi, T.4
Koyama, M.5
Ando, A.6
Miki, T.7
Kumadaki, I.8
-
10
-
-
0034670496
-
-
(a) Coles, S. J.; Mellor, J. M.; El-Sagheer, A. H.; E. E. E. Salem, M.; Metwally, R. N. Tetrahedron 2000, 56, 10057-10066.
-
(2000)
Tetrahedron
, vol.56
, pp. 10057-10066
-
-
Coles, S.J.1
Mellor, J.M.2
El-Sagheer, A.H.3
E E E Salem, M.4
Metwally, R.N.5
-
17
-
-
0030778029
-
-
Corey, E. J.; Lee, J.; Roberts, B. E. Tetrahedron Lett. 1997, 38, 8915-8918.
-
(1997)
Tetrahedron Lett.
, vol.38
, pp. 8915-8918
-
-
Corey, E.J.1
Lee, J.2
Roberts, B.E.3
-
19
-
-
0001553502
-
-
Lipshutz, B. H.; Koerner, M.; Parker, D. A. Tetrahedron Lett. 1987, 28, 945-948.
-
(1987)
Tetrahedron Lett.
, vol.28
, pp. 945-948
-
-
Lipshutz, B.H.1
Koerner, M.2
Parker, D.A.3
-
20
-
-
0037261488
-
-
(a) Vosburg, D. A.; Weiler, S.; Sorensen, E. J. Chirality 2003, 15, 156-166.
-
(2003)
Chirality
, vol.15
, pp. 156-166
-
-
Vosburg, D.A.1
Weiler, S.2
Sorensen, E.J.3
-
21
-
-
0033119793
-
-
(b) Vosburg, D. A.; Weiler, S.; Sorensen, E. J. Angew. Chem., Int. Ed. 1999, 38, 971-974.
-
(1999)
Angew. Chem., Int. Ed.
, vol.38
, pp. 971-974
-
-
Vosburg, D.A.1
Weiler, S.2
Sorensen, E.J.3
-
22
-
-
0037266148
-
-
Compound 17 was prepared in a few steps from the known 4-(4-methoxy-benzyloxy)-cyclohexanone (Spino, C.; Hill, B.; Dube, P.; Gingras, S. Can. J. Chem. 2003, 81, 81-108); the ketone was converted to the corresponding enol triflate and the latter was converted to 17 as described in the preparation of 14 (see Supporting Information for details).
-
(2003)
Can. J. Chem.
, vol.81
, pp. 81-108
-
-
Spino, C.1
Hill, B.2
Dube, P.3
Gingras, S.4
-
23
-
-
15444369188
-
-
note
-
At the time this work was in progress, the enantioselective synthesis of the required Sorensen's intermediate had not been disclosed (ref 14a).
-
-
-
-
24
-
-
0033575093
-
-
Taber, D. F.; Christos, T. E.; Rheingold, A. L.; Guzei, I. A. J. Am. Chem. Soc. 1999, 121, 5589-5590.
-
(1999)
J. Am. Chem. Soc.
, vol.121
, pp. 5589-5590
-
-
Taber, D.F.1
Christos, T.E.2
Rheingold, A.L.3
Guzei, I.A.4
-
26
-
-
15444369389
-
-
(a) Rubottom, G. M.; Vazquez, M. A.; Pellagrina, D. R. Tetrahedron Lett. 1995, 36, 2423-2426.
-
(1995)
Tetrahedron Lett.
, vol.36
, pp. 2423-2426
-
-
Rubottom, G.M.1
Vazquez, M.A.2
Pellagrina, D.R.3
-
27
-
-
15444365109
-
-
(b) Hassner, A.; Reuss, R. H.; Pinnick, H. W. J. Org. Chem. 2004, 69, 357-373.
-
(2004)
J. Org. Chem.
, vol.69
, pp. 357-373
-
-
Hassner, A.1
Reuss, R.H.2
Pinnick, H.W.3
|